Close
Nordic 9Nordic 9

MVM Life Science Partners (investor - Venture Capital)

United Kingdom mvm.com
See something wrong or missing? Let us know
Offices:London

MVM Life Science Partners is a venture capital firm specializing in investments in start-up, early stage, mid venture, late venture.

Average round investment:50.87M USD
Average number per year:1.0
Distribution: 2025 (1)2020 (1)2015 (1)
Portfolio companies: Ireland ProVerumSwitzerland SkyCellFinland Onbone
Mostly invests in: Ireland Ireland (1) Pharma (2)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to MVM Life Science Partners

Name Criteria
United States Acorn Bioventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Ireland, Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Ireland Cantor Fitzgerald Private Clients
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Transportation
  • Similar business models: B2B
  • Common investees countries: Ireland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States KB Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, Finland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Recipharm Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mayo Clinic
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France BOLD - Business Opportunities for L'Oréal Development
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States QVIDTVM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Transportation, Logistics
  • Similar business models: B2B
  • Common investees countries: Ireland, Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Digitalis Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Yamato Holdings
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Transportation, Logistics
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top